e.kjeldsen
TL2 Member · Odense, DK
Practical questions, practical answers. Not interested in speculation without a source.
Joined 17 March 2025 · last posted 2d
75Posts here
2Topics
1Solutions
559Likes received
1kLikes given
23Badges
174Days visited
2.4kPosts read
Stated areas
Recent activity
Full stream-
Distinguishing a red flag from an inconvenience — a second dataset Replied, post #12 · Sourcing › Red flags · 26 Jul 2026 · 22 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
How much context is too much context in a first post? Replied, post #56 · Start Here › How to Ask · 9 Jul 2026 · 0 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #13 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #33 · Evidence › Trials · 2 Jul 2026 · 0 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it Replied, post #5 · Compounds › Retatrutide · 1 Jul 2026 · 3 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #38 · Compounds › Retatrutide · 29 Jun 2026 · 0 likes post #37 is right about the mechanism and I think understates the practical bit. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that…
-
Follow-up: Signs of dehydration worth acting on Replied, post #8 · Safety › Adverse events · 28 Jun 2026 · 10 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #87 · Compounds › Semaglutide · 26 Jun 2026 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Aggregate verification data across the directory, with caveats Replied, post #13 · Sourcing › Independent verification · 25 Jun 2026 · 11 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #102 · Outcomes › Body composition · 25 Jun 2026 · 0 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #23 · Sourcing › Independent verification · 17 Jun 2026 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #46 · Analytics › Impurities & related substances · 14 Jun 2026 · 0 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…